Tarik Soliman Selected to Pitch at the Life Sciences Summit, Sponsored by the NCI
Dr. Soliman was selected by the National Cancer Institute for their Investor Initiatives program, a once-yearly competitive program that connects SBIR-funded companies with potential investors and strategic partners to continue the commercialization efforts initially funded by NCI. He received executive coaching on his presentation, EXT418 for the Treatment of Cancer Cachexia, in preparation for pitching at the Emerging Company Showcase at the Life Sciences Summit held in New York City. Extend Biosciences also received financial assistance from NCI to cover the presentation and registration costs for the conference.